Related Experiment Video
Updated: Apr 15, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
11.2K
[Inflammatory cerebral amyloid angiopathy]
Yuichiro Ii1, Hidekazu Tomimoto
1Department of Neurology, Mie University Graduate School of Medicine.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|April 8, 2015
Summary
Inflammatory cerebral amyloid angiopathy (CAA) presents with neurological symptoms and distinct MRI findings. Early recognition may allow for effective immunosuppressive treatment, potentially improving outcomes.
Area of Science:
- Neurology
- Immunology
- Neuroradiology
Context:
- Inflammatory cerebral amyloid angiopathy (CAA) is a condition affecting older adults.
- It presents with acute neurological symptoms like cognitive decline and seizures.
- Brain MRI reveals characteristic white matter changes and microhemorrhages.
Purpose:
- To describe the clinical, imaging, and neuropathological features of inflammatory CAA.
- To highlight potential treatment responses to immunosuppression.
- To discuss the relationship between inflammatory CAA and amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease.
Summary:
- Inflammatory CAA involves vasculitis and inflammation around amyloid-beta-laden vessels.
- MRI shows white matter edema and lobar hemorrhages/microbleeds.
- Patients may benefit from corticosteroids or cyclophosphamide.
Impact:
- Identifies inflammatory CAA as a treatable condition with immunosuppressive therapy.
- Suggests anti-amyloid-beta autoantibodies as potential biomarkers for future therapies.
- Differentiates inflammatory CAA from other causes of cognitive decline and cerebrovascular disease.
